News
STE
207.89
+2.69%
5.45
STERIS plc's (NYSE:STE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 18% over the past three months, it is easy to disregard STERIS (NYSE:STE). However, the company's...
Simply Wall St. · 06/18 12:58
Ominous Death Cross Forms On Steris's Chart
If history is any guide, there may be trouble ahead for shares of Steris (NYSE:STE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Benzinga · 06/17 15:17
Steris (STE) Up 1.5% Since Last Earnings Report: Can It Continue?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 06/10 15:30
Here's Why You Should Hold STERIS (STE) Stock in Your Portfolio
Investors are optimistic about STERIS (STE) due to its strong fiscal fourth-quarter results.
Zacks · 05/17 13:41
STERIS (STE) Q4 Earnings Surpass Estimates, Gross Margin Rises
Robust performances across all four reporting segments drive STERIS' (STE) fiscal fourth-quarter revenues.
Zacks · 05/12 14:27
--Needham Lowers Price Target for STERIS to $248 From $263, Maintains Buy Rating
MT Newswires · 05/12 14:17
BRIEF-Steris Announces Results For Fiscal 2022 Fourth Quarter And Full Year
reuters.com · 05/11 22:32
Steris: Q4 Earnings Insights
Steris (NYSE:STE) reported its Q4 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 0.99%, reporting an EPS of $2.04 versus an estimate of $2.02.
Benzinga · 05/11 20:56
Steris Non-GAAP EPS of $2.04 beats by $0.02, revenue of $1.2B beats by $30M
Steris press release (NYSE:STE): Q4 Non-GAAP EPS of $2.04 beats by $0.02. Revenue of $1.2B (+37.4% Y/Y) beats by $30M. Outlook: For fiscal 2023, constant currency organic revenue growth is
Seekingalpha · 05/11 20:36
Steris Q4 EPS $2.04 Beats $2.02 Estimate, Sales $1.20B Beat $1.19B Estimate
Steris (NYSE:STE) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $2.02 by 0.99 percent. This is a 25.15 percent increase over earnings of $1.63 per share from the same period
Benzinga · 05/11 20:35
STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year
Fourth quarter revenue increases 39% as reported; 11% constant currency organicAs reported EPS of $0.52; adjusted EPS of $2.04Company provides FY23 outlook DUBLIN, IRELAND, May 11, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”)...
GlobeNewswire · 05/11 20:30
STERIS Fiscal Q4 Adjusted EPS, Revenue Rise; Sets Fiscal 2023 Guidance
MT Newswires · 05/11 16:54
Steris FQ4 2022 consensus EPS, revenue estimates up
Steris (NYSE:STE) FQ4 consensus EPS estimate is $2.02 (+23.9% Y/Y) and consensus revenue estimate is $1.17B (+33.9% Y/Y). STE is scheduled to announce FQ4 earnings results on Wednesday, May 11, after market close.
Seekingalpha · 05/10 21:35
STERIS (STE) to Report Q4 Earnings: What's in the Cards?
Strength in Healthcare and AST arms is expected to have driven STERIS' (STE) fourth-quarter revenues.
Zacks · 05/06 14:56
Investing in STERIS (NYSE:STE) five years ago would have delivered you a 220% gain
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Simply Wall St. · 05/05 12:19
Steris declares $0.43 dividend
Steris (NYSE:STE) declares $0.43/share quarterly interim dividend, in line with previous. Forward yield 0.74% Payable June 28; for shareholders of record June 14; ex-div June 13. See STE Dividend Scorecard,
Seekingalpha · 05/04 20:36
STERIS Declares $0.43 per share Dividend
DUBLIN, IRELAND , May 04, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.43 per share. The dividend is payable June 28, 2022 to shareholders of...
GlobeNewswire · 05/04 20:30
Here's Why You Should Retain Quest Diagnostics (DGX) Stock Now
Investors are optimistic about Quest Diagnostics (DGX) owing to a strong recovery in base business and raised 2022 outlook.
Zacks · 05/03 13:30
STERIS to Host a Conference Call for Fiscal 2022 Fourth Quarter and Full Year Financial Results on May 12, 2022
DUBLIN, IRELAND, April 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 fourth quarter and full year financial results at 10:00 a.m. ET on May 12,...
GlobeNewswire · 04/25 20:30
Globus Medical (GMED) Stock Fell on Preliminary Q1 Sales Results
Globus Medical's (GMED) Q1 preliminary sales results reflect an increase in procedural volumes along with growth in Enabling Technologies business.
Zacks · 04/22 15:05
More
Webull provides a variety of real-time STE stock news. You can receive the latest news about Steris Plc through multiple platforms. This information may help you make smarter investment decisions.
About STE
STERIS plc is a provider of infection prevention and other procedural products and services. The Company offers a mix of consumable products, such as detergents, gastrointestinal (GI) endoscopy accessories, barrier product solutions, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, dental instruments and tools, instrument and scope repair solutions, laboratory testing services, outsourced reprocessing, and capital equipment products, such as sterilizers and surgical tables, automated endoscope reprocessors, and connectivity solutions such as operating room (OR) integration. The Company operates through four reportable business segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. Its Healthcare segment focused on sterile processing departments and procedural centers, such as operating rooms, endoscopy suites, and renal dialysis centers.